1. Chen, Wei, Hu, Yang, Ju, Dianwen. 2020. Gene therapy for neurodegenerative disorders: advances, insights and prospects. In Acta pharmaceutica Sinica. B, 10, 1347-1359. doi:10.1016/j.apsb.2020.01.015. https://pubmed.ncbi.nlm.nih.gov/32963936/
2. Cain, Jacob T, Likhite, Shibi, White, Katherine A, Meyer, Kathrin, Weimer, Jill M. 2019. Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease. In Molecular therapy : the journal of the American Society of Gene Therapy, 27, 1836-1847. doi:10.1016/j.ymthe.2019.06.015. https://pubmed.ncbi.nlm.nih.gov/31331814/
3. White, Katherine A, Nelvagal, Hemanth R, Poole, Timothy A, Wang, Shaomei, Weimer, Jill M. 2021. Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice. In Molecular therapy. Methods & clinical development, 20, 497-507. doi:10.1016/j.omtm.2020.12.014. https://pubmed.ncbi.nlm.nih.gov/33665223/
4. Otero, Maria Gabriela, Kim, Jaemin, Kushwaha, Yogesh Kumar, Salamon, Noriko, Pierson, Tyler Mark. 2024. Cellular Modeling of CLN6 with IPSC-derived Neurons and Glia. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.01.29.577876. https://pubmed.ncbi.nlm.nih.gov/38352418/
5. Kleine Holthaus, Sophia-Martha, Herranz-Martin, Saul, Massaro, Giulia, Rahim, Ahad A, Ali, Robin R. . Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease. In Human molecular genetics, 28, 3867-3879. doi:10.1093/hmg/ddz210. https://pubmed.ncbi.nlm.nih.gov/31807779/